Metis TechBio Market Cap

Metis TechBio has a market cap or net worth of 16.75 billion as of June 18, 2026.

Market Cap

16.75B

Enterprise Value

15.64B

Revenue

116.85M

Ranking

n/a

PE Ratio

n/a

Stock Price

14.41

Market Cap Chart

Since May 13, 2026, Metis TechBio's market cap has decreased from 27.43B to 16.75B, a decrease of -38.95%. That is a compound annual growth rate of -99.33%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2026	16.75B	-
Jun 17, 2026	16.75B	0.90%
Jun 16, 2026	16.60B	0.07%
Jun 15, 2026	16.58B	9.10%
Jun 12, 2026	15.20B	2.73%
Jun 11, 2026	14.80B	5.51%
Jun 10, 2026	14.03B	-5.95%
Jun 9, 2026	14.91B	-1.52%
Jun 8, 2026	15.14B	-6.54%
Jun 5, 2026	16.20B	-1.54%
Jun 4, 2026	16.46B	-9.16%
Jun 3, 2026	18.12B	3.56%
Jun 2, 2026	17.50B	1.20%
Jun 1, 2026	17.29B	1.49%
May 29, 2026	17.03B	-8.37%
May 28, 2026	18.59B	-6.60%
May 27, 2026	19.90B	5.50%
May 26, 2026	18.87B	-3.02%
May 22, 2026	19.45B	3.12%
May 21, 2026	18.87B	-9.06%
May 20, 2026	20.75B	-10.27%
May 19, 2026	23.12B	-14.13%
May 18, 2026	26.92B	7.65%
May 15, 2026	25.01B	-14.03%
May 14, 2026	29.09B	6.05%
May 13, 2026	27.43B	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genscript Biotech	25.82B
InnoCare Pharma	22.83B
Keymed Biosciences	17.15B
Duality Biotherapeutics	17.01B
Zai Lab	15.03B
TransThera Sciences (Nanjing)	12.90B
TenNor Therapeutics (Suzhou)	12.83B
Ascentage Pharma Group International	12.60B

Market Cap Rankings